Breakthrough infections with SARS-CoV-2 B.1.617.2 variant B.1.617.2 and humoral reponse in vaccinated maintenance hemodialysis patients

O. Wand (Ashkelon, Israel), N. Nacasch (Kfar-Saba, Israel), S. Benchetrit (Kfar-Saba, Israel), K. Cohen-Hagai (Kfar-Saba, Israel)

Source: International Congress 2022 – Vaccination

Session: Vaccination
Session type: Thematic Poster
Number: 1131

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Wand (Ashkelon, Israel), N. Nacasch (Kfar-Saba, Israel), S. Benchetrit (Kfar-Saba, Israel), K. Cohen-Hagai (Kfar-Saba, Israel). Breakthrough infections with SARS-CoV-2 B.1.617.2 variant B.1.617.2 and humoral reponse in vaccinated maintenance hemodialysis patients. 1131

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.